Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$35,933,056
+$11,574,368 QoQ
Shares Held
421,799
+14.1% QoQ
Ownership
0.303%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#68
of 477 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CYTK ranks #9 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CYTK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,933,056 | 421,799 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $24,358,688 | 369,575 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $22,683,462 | 356,995 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,204,282 | 385,813 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,883,617 | 389,940 | Shares | Sole | 2025-08-12 | |
| 2024-09-30 | $19,994,092 | 378,676 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,548,144 | 379,257 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $21,498,460 | 306,639 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $23,530,988 | 281,842 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $8,097,640 | 274,869 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,868,203 | 271,864 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $9,117,658 | 259,098 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $11,338,525 | 247,458 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,626,643 | 239,972 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,559,247 | 217,848 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,438,307 | 202,073 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $8,547,207 | 187,521 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,683,237 | 186,996 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,870,943 | 195,601 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,726,827 | 203,217 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $4,128,549 | 198,679 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,037,811 | 186,504 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,108,698 | 174,319 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,129,663 | 180,633 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||